PAH and phenylketonuria: Here, we report a synthetic mammalian self-regulation system designed to dynamically respond to l-phenylalanine (Phe), an essential amino acid that accumulates to toxic levels in patients with phenylketonuria (PKU) due to mutations in the Phe hydroxylase (PAH) gene, leading to severe neurotoxicity [10–13].